Introducing the China PIII: A New Benchmark for Pharmaceutical Innovation in China
Shanghai, China – June 10, 2025 – As China advances its national strategy to foster pharmaceutical innovation and drive high-quality […]
Shanghai, China – June 10, 2025 – As China advances its national strategy to foster pharmaceutical innovation and drive high-quality […]
READING, Pa.–(BUSINESS WIRE)–SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device
READING, Pa.–(BUSINESS WIRE)–SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device
READING, Pa.–(BUSINESS WIRE)–SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device
BETHESDA, Md.–(BUSINESS WIRE)–Northlane Capital Partners (“NCP”) announced today that it has made an investment in SAI MedPartners (“SAI”), a leading